Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma (ACC)-Specific Prognostic Relevance
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma (ACC)-Specific Prognostic Relevance
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages 100371
Publisher
Elsevier BV
Online
2023-10-28
DOI
10.1016/j.modpat.2023.100371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors
- (2022) George D. Demetri et al. CLINICAL CANCER RESEARCH
- Phase II Study of Enzalutamide for Patients With Androgen Receptor–Positive Salivary Gland Cancers (Alliance A091404)
- (2022) Alan L. Ho et al. JOURNAL OF CLINICAL ONCOLOGY
- AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling
- (2022) Renata Ferrarotto et al. Cell Death & Disease
- B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition
- (2022) Xiaotian Yan et al. BMC CANCER
- Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
- (2022) Krista Kinneer et al. CLINICAL CANCER RESEARCH
- Management of Salivary Gland Malignancy: ASCO Guideline
- (2021) Jessica L. Geiger et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified
- (2021) Luana G. Sousa et al. CANCER
- The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
- (2021) Nadia Bolandi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype
- (2020) Luc GT Morris et al. CLINICAL CANCER RESEARCH
- Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
- (2020) Larissa Di Villeneuve et al. Frontiers in Oncology
- Defining the Hallmarks of Metastasis
- (2019) Danny R. Welch et al. CANCER RESEARCH
- Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
- (2018) Ling Wang et al. Cancer Cell International
- B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer
- (2017) Lingwei Shen et al. HUMAN PATHOLOGY
- Potential targeting of B7-H4 for the treatment of cancer
- (2017) Joseph R. Podojil et al. IMMUNOLOGICAL REVIEWS
- B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells
- (2017) Xiaomei Li et al. International Journal of Rheumatic Diseases
- Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
- (2017) Renata Ferrarotto et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunosuppressive Effect of B7-H4 Pathway in a Murine Systemic Lupus Erythematosus Model
- (2017) Ze Xiu Xiao et al. Frontiers in Immunology
- Combination chemotherapy of carboplatin and paclitaxel for advanced/metastatic salivary gland carcinoma patients: differences in responses by different pathological diagnoses
- (2016) Kenji Nakano et al. ACTA OTO-LARYNGOLOGICA
- A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
- (2016) A. L. Ho et al. ANNALS OF ONCOLOGY
- In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type
- (2016) Diana Bell et al. CANCER
- A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
- (2016) L.D. Locati et al. EUROPEAN JOURNAL OF CANCER
- B7-H4 expression in ovarian serous carcinoma: a study of 306 cases
- (2016) Li Liang et al. HUMAN PATHOLOGY
- An Anti-B7-H4 Antibody–Drug Conjugate for the Treatment of Breast Cancer
- (2015) Steven R. Leong et al. MOLECULAR PHARMACEUTICS
- Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications
- (2014) Y. Mitani et al. CLINICAL CANCER RESEARCH
- Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
- (2013) David J. Thomson et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance
- (2010) M. D. Williams et al. CLINICAL CANCER RESEARCH
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
- (2010) Scott A Laurie et al. LANCET ONCOLOGY
- Fine tuning the immune response through B7-H3 and B7-H4
- (2009) Kyung H. Yi et al. IMMUNOLOGICAL REVIEWS
- Potential Role of Decoy B7-H4 in the Pathogenesis of Rheumatoid Arthritis: A Mouse Model Informed by Clinical Data
- (2009) Takeshi Azuma et al. PLOS MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started